Patents by Inventor Addolorata PISCONTI

Addolorata PISCONTI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210315873
    Abstract: The present disclosure is directed to methods of treatment, including treatment of a myopathy by administering to a subject in need thereof an elastase inhibitor in combination with a glucocorticoid. The present disclosure is also directed to pharmaceutical compositions that include an elastase inhibitor that can be used in such treatment.
    Type: Application
    Filed: April 13, 2021
    Publication date: October 14, 2021
    Applicants: The Research Foundation for The State University of New York, The University of Liverpool
    Inventors: Addolorata Pisconti, Fiona Kate Jones, Kirsty Anne Johnson
  • Publication number: 20210196694
    Abstract: The invention provides anelastase inhibitor for use in the promotion of muscle regeneration in the treatment of a myopa-thy, as well as a method for promoting muscle regeneration in a subject with a myopathy, the method comprising providing the subject with a therapeutically effective amount of an elastase inhibitor. Further provided is a pharmaceutical composition comprising anelastase inhibitor for use in the promotion of muscle regeneration in the treatment of a myopathy. Elastase inhibitors may have a protective effect on muscle progenitor cells and their regenerative potential, which aids muscle cell regeneration. By protecting regenerative potential of muscle progenitor cells, elastase inhibitors enable or enhance the grown of new or existing muscle fibres.
    Type: Application
    Filed: November 25, 2020
    Publication date: July 1, 2021
    Applicant: The Research Foundation for The State University of New York
    Inventor: Addolorata PISCONTI
  • Patent number: 10874652
    Abstract: The invention provides anelastase inhibitor for use in the promotion of muscle regeneration in the treatment of a myopathy, as well as a method for promoting muscle regeneration in a subject with a myopathy, the method comprising providing the subject with a therapeutically effective amount of an elastase inhibitor. Further provided is a pharmaceutical composition comprising anelastase inhibitor for use in the promotion of muscle regeneration in the treatment of a myopathy. Elastase inhibitors may have a protective effect on muscle progenitor cells and their regenerative potential, which aids muscle cell regeneration. By protecting regenerative potential of muscle progenitor cells, elastase inhibitors enable or enhance the grown of new or existing muscle fibres.
    Type: Grant
    Filed: May 15, 2017
    Date of Patent: December 29, 2020
    Assignee: The Research Foundation for The State University of New York
    Inventor: Addolorata Pisconti
  • Publication number: 20190134014
    Abstract: The invention provides anelastase inhibitor for use in the promotion of muscle regeneration in the treatment of a myopathy, as well as a method for promoting muscle regeneration in a subject with a myopathy, the method comprising providing the subject with a therapeutically effective amount of an elastase inhibitor. Further provided is a pharmaceutical composition comprising anelastase inhibitor for use in the promotion of muscle regeneration in the treatment of a myopathy. Elastase inhibitors may have a protective effect on muscle progenitor cells and their regenerative potential, which aids muscle cell regeneration. By protecting regenerative potential of muscle progenitor cells, elastase inhibitors enable or enhance the grown of new or existing muscle fibres.
    Type: Application
    Filed: May 15, 2017
    Publication date: May 9, 2019
    Applicant: THE UNIVERSITY OF LIVERPOOL
    Inventor: Addolorata PISCONTI